Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Idiopathic intracranial hypertension

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Papilloedema with rapidly worsening acuity or visual fields, severe hypertension, altered consciousness, focal deficit or an acute atypical headache requires urgent same-day hospital, ophthalmology and neurology assessment. Fulminant visual decline may need emergency cerebrospinal-fluid diversion or optic-nerve-sheath surgery; repeated outpatient lumbar puncture is not an adequate vision-saving plan.

Synopsis

Confirm raised intracranial pressure safely after excluding secondary causes, protect vision through structured ophthalmic monitoring, and use weight, medicine or surgery according to visual risk.

  • Idiopathic intracranial hypertension is raised intracranial pressure with normal cerebrospinal-fluid composition and no mass, hydrocephalus, venous thrombosis or other secondary cause on appropriate investigation.
  • Headache is common but non-specific; papilloedema, transient visual obscurations, pulsatile tinnitus and sixth-nerve palsy provide more diagnostic and risk information.
  • Confirm suspected papilloedema with competent ophthalmic assessment, documenting visual acuity, pupils, formal visual fields and optic-disc appearance or imaging.
  • Urgent MRI or CT must exclude structural disease, and CT or MR venography is required to exclude cerebral venous sinus thrombosis before the condition is called idiopathic.
  • After safe normal imaging, perform lumbar puncture in the lateral decubitus position with a relaxed patient, measure opening pressure correctly and analyse normal CSF constituents.
  • An adult opening pressure above 25 cm CSF supports diagnosis, but a single measurement must be interpreted with the complete phenotype, technique and imaging.
  • Weight loss is the only established disease-modifying therapy in patients with obesity; frame support respectfully and offer access to structured weight-management services.
  • Acetazolamide can be used to protect visual function in selected patients, but it is not established as a treatment for headache alone and adverse effects often limit dosing.
  • Serial therapeutic lumbar punctures are not recommended for routine management because benefit is short-lived; deteriorating vision needs definitive specialist escalation.

Key red flags

Papilloedema syndrome

Bilateral optic-disc swelling with transient visual obscurations, headache or pulsatile tinnitus raises intracranial-pressure concern and needs urgent competent visual assessment.

Sixth-nerve palsy

Horizontal diplopia from an abduction deficit can occur as a false localising sign; other cranial or limb deficits should prompt a search for an alternative lesion.

Fulminant IIH

Rapid visual-acuity or field decline over days to weeks represents sight-threatening disease and requires immediate surgical-level escalation rather than routine medication titration.

Pressure-type visual symptoms

Brief binocular dimming with postural change, enlarging blind spot or progressive peripheral field loss can signal optic-nerve compromise even when central acuity remains good.

Secondary pressure clue

Pregnancy or puerperium, thrombosis risk, anaemia, tetracycline or vitamin-A exposure, steroid withdrawal, endocrine disease or systemic symptoms demands an active search for secondary intracranial hypertension.

Investigation priorities

01
Formal ophthalmic assessmentFirst step

Confirm papilloedema and establish visual acuity, pupils, colour, perimetry, fundus grade and optic-nerve imaging baseline.

Management branches

Suspected papilloedemaProtect sight while confirming pressure

Disc swelling or pressure-related visual symptoms are identified.

  1. Measure blood pressure, acuity, pupils and fields urgently, obtain experienced confirmation of papilloedema and identify rapidly changing vision.
  2. Arrange urgent brain imaging with venography to exclude mass, hydrocephalus and cerebral venous sinus thrombosis before lumbar puncture.
  3. When safe, perform a technically correct lateral-decubitus lumbar puncture with opening pressure and normal-composition studies.
  4. Coordinate neurology and ophthalmology so diagnosis, visual-risk grade and ownership of follow-up are explicit from the outset.
Stable visionModify disease and monitor function

IIH is confirmed without rapidly deteriorating visual function.

  1. Explain the diagnosis and visual risk, review secondary associations and provide a respectful supported weight-management referral where obesity is present.
  2. Consider acetazolamide for visual protection, titrating through specialist or local protocol while monitoring tolerability, renal risk and acid-base effects.
  3. Treat migraine-like headache with an appropriate acute and preventive plan, limiting rescue days and avoiding routine repeated lumbar puncture.

Key medicines

AcetazolamideA common specialist start is 250–500 mg twice daily, titrated according to visual response, adverse effects, renal function and the local IIH protocol.Paraesthesia, fatigue, gastrointestinal symptoms, taste change, renal stones and metabolic acidosis are common concerns; review renal disease, electrolytes, sulfonamide reactions and pregnancy.
TopiramateIf selected by a specialist, begin at a low nightly dose and titrate slowly using migraine guidance and the lowest effective tolerated regimen.Cognitive and mood effects, stones and acute angle closure matter; it is contraindicated for migraine prevention in pregnancy and MHRA Pregnancy Prevention Programme conditions apply.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • UK consensus guidelines on IIH managementMultispecialty diagnostic, visual-monitoring, weight, medicine and surgical pathway.
  • Practical Neurology IIH diagnosis and management updateUK clinical application of pressure measurement, imaging and follow-up.
  • BNF acetazolamide monographContraindications, adverse effects, interactions and prescribing safety.
  • MHRA topiramate pregnancy prevention measuresCurrent reproductive safety restrictions relevant to migraine-pattern headache treatment.
  • NICE CG150 headache diagnosis guidanceHeadache assessment, diary use and secondary-feature principles.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Schedule perimetry and optic-disc review at an interval determined by papilloedema grade, field loss and trajectory, shortening it for any concern.